These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11576798)

  • 1. Xerostomia in patients with advanced cancer.
    Davies AN; Broadley K; Beighton D
    J Pain Symptom Manage; 2001 Oct; 22(4):820-5. PubMed ID: 11576798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary gland hypofunction in patients with advanced cancer.
    Davies AN; Broadley K; Beighton D
    Oral Oncol; 2002 Oct; 38(7):680-5. PubMed ID: 12167420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of the clinical value of total salival flow rates].
    Wang S; Zhao Z; Li J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1998 Nov; 33(6):360-2. PubMed ID: 11774443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the clinical value of total saliva flow rates.
    Wang SL; Zhao ZT; Li J; Zhu XZ; Dong H; Zhang YG
    Arch Oral Biol; 1998 Jan; 43(1):39-43. PubMed ID: 9569989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulated whole salivary flow rate: The most appropriate technique for assessing salivary flow in Sjögren syndrome.
    Alvariño C; Bagan L; Murillo-Cortes J; Calvo J; Bagan J
    Med Oral Patol Oral Cir Bucal; 2021 May; 26(3):e404-e407. PubMed ID: 33772564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hyposalivation in relation to general health, body mass index and remaining teeth in different age groups of adults.
    Flink H; Bergdahl M; Tegelberg A; Rosenblad A; Lagerlöf F
    Community Dent Oral Epidemiol; 2008 Dec; 36(6):523-31. PubMed ID: 18422708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xerostomia: aetiology and management in cancer patients.
    Holmes S
    Support Care Cancer; 1998 Jul; 6(4):348-55. PubMed ID: 9695202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Dysgeusia in Patients With Oropharyngeal Cancer Treated With Chemotherapy and Intensity Modulated Radiation Therapy.
    Sapir E; Tao Y; Feng F; Samuels S; El Naqa I; Murdoch-Kinch CA; Feng M; Schipper M; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):354-361. PubMed ID: 27473816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of xerostomia and hyposalivation in the nursing home and the relation with number of prescribed medication].
    van der Putten GJ; Brand HS; Bots CP; van Nieuw Amerongen A
    Tijdschr Gerontol Geriatr; 2003 Feb; 34(1):30-6. PubMed ID: 12629908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral candidosis in community-based patients with advanced cancer.
    Davies AN; Brailsford SR; Beighton D; Shorthose K; Stevens VC
    J Pain Symptom Manage; 2008 May; 35(5):508-14. PubMed ID: 18242047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xerostomia and hypofunction of the salivary glands in cancer therapy.
    Jensen SB; Pedersen AM; Reibel J; Nauntofte B
    Support Care Cancer; 2003 Apr; 11(4):207-25. PubMed ID: 12673459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dry mouth--oral care for patients with oligoliasia and xerostomia].
    Rath C; Imfeld T
    Ther Umsch; 2008 Feb; 65(2):91-6. PubMed ID: 18517063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Buccal dryness, xerostomia and measurement of salivary secretory activity].
    Jehl-Pietri C; Monteil R; Madinier I; Raybaud-Diogène H; Bracco M
    Ann Med Interne (Paris); 1997; 148(3):209-16. PubMed ID: 9255328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of candy weight loss rate with whole saliva flow rates.
    Yamamoto K; Matsusue Y; Komatsu Y; Kurihara M; Nakagawa Y; Kirita T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):e10-4. PubMed ID: 21458319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xerostomia in diabetes mellitus.
    Sreebny LM; Yu A; Green A; Valdini A
    Diabetes Care; 1992 Jul; 15(7):900-4. PubMed ID: 1516511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.
    Jensen SB; Pedersen AM; Vissink A; Andersen E; Brown CG; Davies AN; Dutilh J; Fulton JS; Jankovic L; Lopes NN; Mello AL; Muniz LV; Murdoch-Kinch CA; Nair RG; Napeñas JJ; Nogueira-Rodrigues A; Saunders D; Stirling B; von Bültzingslöwen I; Weikel DS; Elting LS; Spijkervet FK; Brennan MT;
    Support Care Cancer; 2010 Aug; 18(8):1039-60. PubMed ID: 20237805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 diabetes mellitus, xerostomia, and salivary flow rates.
    Moore PA; Guggenheimer J; Etzel KR; Weyant RJ; Orchard T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Sep; 92(3):281-91. PubMed ID: 11552145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of oral side effects of chemotherapy and its relationship with periodontal risk: a cross sectional study.
    García-Chías B; Figuero E; Castelo-Fernández B; Cebrián-Carretero JL; Cerero-Lapiedra R
    Support Care Cancer; 2019 Sep; 27(9):3479-3490. PubMed ID: 30675665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supragingival and subgingival microbiota from patients with poor oral hygiene submitted to radiotherapy for head and neck cancer treatment.
    Gaetti-Jardim E; Jardim ECG; Schweitzer CM; da Silva JCL; Oliveira MM; Masocatto DC; Dos Santos CM
    Arch Oral Biol; 2018 Jun; 90():45-52. PubMed ID: 29533791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary flow rate and clinical characteristics of patients with xerostomia according to its aetiology.
    Cho MA; Ko JY; Kim YK; Kho HS
    J Oral Rehabil; 2010 Mar; 37(3):185-93. PubMed ID: 20002531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.